Does the company plan any share buybacks or dividend adjustments based on this quarter’s performance?

Answer: The Q2 2025 earnings release from IM Cannabis Corp. (NASDAQ: IMCC) does not disclose any planned share‑buyback program or changes to the company’s dividend policy. The company’s press‑release focuses on “strong profit and margin growth” but makes no reference to capital return initiatives—either a repurchase of common stock or a dividend adjustment—either for this quarter or looking ahead.

Trading implications:

- Fundamentals: The strong earnings and margin improvement are positive catalysts, but without a confirmed buyback or dividend hike, the stock lacks a near‑term dividend‑or‑share‑repurchase catalyst that often supports price appreciation in a low‑interest‑rate environment. Investors should focus on the underlying earnings momentum rather than expecting a near‑term price boost from capital return announcements.

- Technical / market reaction: In the absence of a capital‑return signal, the stock’s price action will likely be driven by the earnings beat versus consensus estimates and the market’s assessment of the company’s growth outlook. Traders may consider a moderate long‑position if the price consolidates above the recent 20‑day moving average with volume support, but should keep a tight stop below the 50‑day moving average to protect against a pull‑back if investors interpret the lack of a buyback/dividend as a sign that management is prioritizing reinvestment over shareholder returns.